State Street’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-639,804
| Closed | -$21.7M | – | 4326 |
|
|
2025
Q4 | $21.7M | Buy |
639,804
+602,421
| +1,611% | +$18.7M | ﹤0.01% | 2228 |
|
|
2025
Q3 | $964K | Buy |
37,383
+18,321
| +96% | +$240K | ﹤0.01% | 3520 |
|
|
2025
Q2 | $152K | Sell |
19,062
-72,917
| -79% | -$556K | ﹤0.01% | 3892 |
|
|
2025
Q1 | $898K | Buy |
91,979
+4,573
| +5% | +$45K | ﹤0.01% | 3455 |
|
|
2024
Q4 | $1.1M | Buy |
87,406
+2,467
| +3% | +$31.3K | ﹤0.01% | 3469 |
|
|
2024
Q3 | $1.37M | Buy |
84,939
+966
| +1% | +$19.5K | ﹤0.01% | 3425 |
|
|
2024
Q2 | $2.05M | Buy |
83,973
+1,548
| +2% | +$71.5K | ﹤0.01% | 3311 |
|
|
2024
Q1 | $5.92M | Sell |
82,425
-99,395
| -55% | -$13.8M | ﹤0.01% | 2860 |
|
|
2023
Q4 | $36.1M | Buy |
181,820
+6,007
| +3% | +$744K | ﹤0.01% | 1879 |
|
|
2023
Q3 | $23.4M | Sell |
175,813
-36,943
| -17% | -$6.03M | ﹤0.01% | 2068 |
|
|
2023
Q2 | $31.8M | Buy |
212,756
+7,875
| +4% | +$1.23M | ﹤0.01% | 1948 |
|
|
2023
Q1 | $30.1M | Sell |
204,881
-37,709
| -16% | -$7.63M | ﹤0.01% | 1968 |
|
|
2022
Q4 | $38.4M | Buy |
242,590
+83,354
| +52% | +$13.3M | ﹤0.01% | 1818 |
|
|
2022
Q3 | $30.6M | Buy |
159,236
+97,878
| +160% | +$18.5M | ﹤0.01% | 1932 |
|
|
2022
Q2 | $8.96M | Sell |
61,358
-107,090
| -64% | -$14.3M | ﹤0.01% | 2794 |
|
|
2022
Q1 | $29.6M | Buy |
168,448
+12,975
| +8% | +$2.45M | ﹤0.01% | 2118 |
|
|
2021
Q4 | $45.7M | Buy |
155,473
+112,368
| +261% | +$30M | ﹤0.01% | 1869 |
|
|
2021
Q3 | $10.7M | Buy |
43,105
+9,298
| +28% | +$2.46M | ﹤0.01% | 2855 |
|
|
2021
Q2 | $8.6M | Buy |
33,807
+9,536
| +39% | +$1.78M | ﹤0.01% | 2991 |
|
|
2021
Q1 | $4.31M | Buy |
24,271
+99
| +0.4% | +$16.3K | ﹤0.01% | 3110 |
|
|
2020
Q4 | $3.82M | Buy |
24,172
+881
| +4% | +$192K | ﹤0.01% | 3099 |
|
|
2020
Q3 | $6M | Buy |
23,291
+1,047
| +5% | +$232K | ﹤0.01% | 2693 |
|
|
2020
Q2 | $5.16M | Buy |
22,244
+19,227
| +637% | +$2.97M | ﹤0.01% | 2742 |
|
|
2020
Q1 | $513K | Buy |
3,017
+1,792
| +146% | +$408K | ﹤0.01% | 3446 |
|
|
2019
Q4 | $271K | Buy |
+1,225
| New | +$225K | ﹤0.01% | 3600 |
|
State Street's RAPT Position: Q1 2026 in Review
State Street sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 639,804 shares — an estimated $21.7M sold.
State Street first reported a position in RAPT in Q4 2019 and held it in 25 quarters. The position peaked at $45.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- State Street reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- State Street sold 639,804 RAPT Therapeutics shares in Q1 2026, an estimated $21.7M.
- State Street first reported a position in RAPT Therapeutics in Q4 2019 and held it in 25 quarters.
- State Street's RAPT Therapeutics position peaked at $45.7M in Q4 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.